Stereotaxis to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
20. Februar 2024 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis Announces First Patients Successfully Treated Using MAGiC Ablation Catheter
08. Januar 2024 08:34 ET
|
Stereotaxis, Inc.
Stereotaxis announces first patients treated using new Magnetic Interventional Catheter, MAGiC
Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients
28. November 2023 08:42 ET
|
Stereotaxis, Inc.
Baptist Health Lexington has become one of the first in the world to provide the latest in robotic technology to treat arrhythmias
Stereotaxis to Participate in Piper Sandler 35th Annual Healthcare Conference
20. November 2023 08:54 ET
|
Stereotaxis, Inc.
Stereotaxis Chairman and CEO, David Fischel, will again participate in the Piper Sandler Healthcare Conference.
Stereotaxis Reports 2023 Third Quarter Financial Results
09. November 2023 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Abbott and Stereotaxis Technologies Used in First Integrated Procedures in the United States
31. Oktober 2023 08:57 ET
|
Stereotaxis, Inc.
Stereotaxis (NYSE: STXS) & Abbott (NYSE:ABT) announce the first patients in the US have been treated successfully utilizing combined technologies
Stereotaxis to Report Third Quarter 2023 Financial Results on November 9, 2023
17. Oktober 2023 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis Robotic Technology to be Featured during 7th Annual Meeting of the Society for Cardiac Robotic Navigation
04. Oktober 2023 08:49 ET
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Heart Centre Rigshospitalet Enhances Leadership in Patient Care with Adoption of Latest Robotic Technology
06. September 2023 08:56 ET
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
Overland Park Regional Medical Center Becomes First U.S. Hospital with Two Stereotaxis Robotic Systems for Arrhythmia Treatment
30. August 2023 08:49 ET
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...